Arthritis: Methotrexate dosage can be scaled down for some patients

September 1995
Modern Medicine;Sep95, Vol. 63 Issue 9, p46
Presents an abstract of the report `Every-other-week methotrexate in patients with rheumatoid arthritis,' by J.M. Kremer et. al. published on the May 1995 issue of `Arthritis Rheumatology'.


Related Articles

  • When methotrexate fails to control rheumatoid arthritis.  // BMJ: British Medical Journal;6/22/2013, Vol. 346 Issue 7913, p11 

    The article focuses on a study conducted to determine the effectiveness of additional sulfasalazine and hydroxychloroquine triple therapy after the effect of methotrexate fails in controlling rheumatoid arthritis in human beings.

  • Methotrexate controls RA symptoms. Rutkowski, John // Arthritis Today;Jan/Feb97, Vol. 11 Issue 1, p33 

    Focuses on the research advances on the effectiveness of methotrexate therapy in the control of the symptoms of rheumatoid arthritis (RA) and the reduction of the need for steroids in both adults and children. Reduction in joint pain, swelling and tenderness; Studies supporting its safety and...

  • Hope for arthritis sufferers...  // FDA Consumer;May/Jun99, Vol. 33 Issue 3, p5 

    Reports on the improvements in patients with rheumatoid arthritis when methotrexate was combined with Enbrel according to researchers at Brigham and Women's Hospital in Boston, Massachusetts. Improvements in pain and swelling; Number of people in the United States afflicted with rheumatoid...

  • Methotrexate safety. Shine, Jerry; Dunkin, Mary Anne // Arthritis Today;May/Jun95, Vol. 9 Issue 3, p9 

    Discusses the results of two separate studies on rheumatoid arthritis (RA) patients indicating that long-term methotrexate treatment for RA may be safer than previously thought. Concerns about side effects; Improvements noted in RA patients given methotrexate.

  • Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study. Ichikawa, Yoichi; Saito, Terunobu; Yamanaka, Hisashi; Akizuki, Masashi; Kondo, Hirobumi; Kobayashi, Shigeto; Oshima, Hisaji; Kawai, Shinichi; Hama, Nobuaki; Yamada, Hidehiro; Mimori, Tsuneyo; Amano, Koichi; Tanaka, Yasushi; Matsuoka, Yasuo; Yamamoto, Sumiki; Matsubara, Tsukasa; Murata, Norikazu; Asai, Tomiaki; Suzuki, Yasuo // Modern Rheumatology (Springer Science & Business Media B.V.);Oct2005, Vol. 15 Issue 5, p323 

    Disease-modifying antirheumatic drug (DMARD) combination therapies are used widely, but there have been few reports clearly demonstrating that combination therapy is more effective than DMARD monotherapy. We conducted a multicenter, double-blind controlled trial in order to clarify that the...

  • Methotrexate inhibits interleukin-6 production in patients with juvenile rheumatoid arthritis. Aggarwal, Amita; Misra, Ramnath // Rheumatology International;May2003, Vol. 23 Issue 3, p134 

    Obejctives. Methotrexate (MTX) is one of the most widely used disease-modifying antirheumatoid drugs in the treatment of juvenile rheumatoid arthritis (JRA). We studied its effect on the production of two proinflammatory cytokines, interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFα),...

  • Biological therapy for rheumatoid arthritis: where are we now? Horton, Sarah C.; Emery, Paul // British Journal of Hospital Medicine (17508460);Jan2012, Vol. 73 Issue 1, p12 

    The article discusses the biological therapies with a range of mechanisms of action for rheumatoid arthritis in patients where conventional disease-modifying anti-rheumatic drug therapy was insufficient to suppress disease activity. The National Institute for Health and Clinical Excellence...

  • Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis. Inoue, Daichi; Arima, Hiroshi; Kawanami, Chiharu; Takiuchi, Yoko; Nagano, Seiji; Kimura, Takaharu; Shimoji, Sonoko; Mori, Minako; Tabata, Sumie; Yanagita, Soshi; Matsushita, Akiko; Nagai, Kenichi; Imai, Yukihiro; Takahashi, Takayuki // Clinical Rheumatology;Oct2010, Vol. 29 Issue 10, p1195 

    64-year-old woman suffering from progressive amyloid A (AA) amyloidosis of the gastrointestinal (GI) tract, associated with active rheumatoid arthritis, was transferred to our hospital due to hypovolemic shock. Although intensive care, including treatment with prednisolone and methotrexate,...

  • Hydroxychloroquine merits a trial in early rheumatoid arthritis.  // Modern Medicine;May94, Vol. 62 Issue 5, p59 

    Presents an abstract of the article entitled, `Hydroxychloroquine compared with placebo in rheumatoid arthritis: A randomized controlled trial,' by P. Clark, E. Casas, P. Tugwell et al as published in the periodical `Annals of Internal Medicine' dated December 1, 1993.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics